SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-19-007497
Filing Date
2019-05-15
Accepted
2019-05-15 17:04:43
Documents
4
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 468894
2 ex31-1.htm EX-31.1 20776
3 ex31-2.htm EX-31.2 20048
4 ex32-1.htm EX-32.1 10582
  Complete submission text file 0001493152-19-007497.txt   521599
Mailing Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010
Business Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010 (212) 994-8200
Protagenic Therapeutics, Inc.\new (Filer) CIK: 0001022899 (see all company filings)

IRS No.: 061390025 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-51353 | Film No.: 19829455
SIC: 7389 Services-Business Services, NEC